Mariana Bucur

806 total citations
21 papers, 592 citations indexed

About

Mariana Bucur is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Mariana Bucur has authored 21 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 8 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Mariana Bucur's work include Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Mariana Bucur is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Mariana Bucur collaborates with scholars based in Germany, Switzerland and Netherlands. Mariana Bucur's co-authors include Volker Schirrmacher, Victor Umansky, Philipp Beckhove, Ben Peeters, Annette Arnold, Philippe Fournier, Katerina Chlichlia, Marian Rocha, Alexey Ushmorov and Carsten Scaffidi and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Mariana Bucur

21 papers receiving 570 citations

Peers

Countries citing papers authored by Mariana Bucur

Since Specialization

Citations

This map shows the geographic impact of Mariana Bucur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariana Bucur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariana Bucur more than expected).

Fields of papers citing papers by Mariana Bucur

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mariana Bucur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariana Bucur. The network helps show where Mariana Bucur may publish in the future.

Co-authorship network of co-authors of Mariana Bucur

This figure shows the co-authorship network connecting the top 25 collaborators of Mariana Bucur. A scholar is included among the top collaborators of Mariana Bucur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariana Bucur. Mariana Bucur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bone marrow expands the repertoire of functional T cells targeting tumor-associated antigens in patients with resectable non-small-cell lung cancer 2019 ·OncoImmunology ·Seyer Safi, Yoshikane Yamauchi, Slava Stamova, Anchana Rathinasamy, (unknown), (unknown), Mariana Bucur, (unknown), Arne Warth, Esther Herpel, Martin Eichhorn, H. Winter, Hans Hoffmann, Philipp Beckhove	6
2	Phase II trial of ipilimumab in melanoma patients with preexisting humoural immune response to NY-ESO-1 2018 ·European Journal of Cancer ·Georg Martin Haag, Inka Zoernig, Jessica C. Hassel, Niels Halama, (unknown), Nina Lang, (unknown), Janet L. Funk, (unknown), (unknown), Mariana Bucur, Ludmila Umansky, Christine S. Falk, Angelika Freitag, Irini Karapanagiotou‐Schenkel, Philipp Beckhove, Alexander Enk, D. Jaeger	13
3	A phase 1 trial extension to assess immunologic efficacy and safety of prime-boost vaccination with VXM01, an oral T cell vaccine against VEGFR2, in patients with advanced pancreatic cancer 2017 ·OncoImmunology ·Friedrich H. Schmitz-Winnenthal, Nicolas Hohmann, Thomas Schmidt, (unknown), (unknown), Heinz Lubenau, (unknown), Sébastien Wieckowski, Klaus M. Breiner, Gerd Mikus, Markus W. Büchler, (unknown), (unknown), Christoph Springfeld, Phillip Knebel, Mariana Bucur, Lars Grenacher, Walter E. Haefeli, Philipp Beckhove	60
4	A phase 1 trial extension to assess immunologic efficacy and safety of prime-boost vaccination with VXM01, an oral T cell vaccine against VEGF-receptor 2, in patients with advanced pancreatic cancer. 2016 ·Journal of Clinical Oncology ·Friedrich H. Schmitz-Winnenthal, (unknown), Nicolas Hohmann, (unknown), Heinz Lubenau, (unknown), Klaus M. Breiner, Gerd Mikus, Markus W. Büchler, (unknown), (unknown), Christoph Springfeld, Phillip Knebel, Thomas Schmidt, Mariana Bucur, Lars Grenacher, Walter E. Haefeli, Philipp Beckhove	1
5	Long-term survival after adoptive bone marrow T cell therapy of advanced metastasized breast cancer: follow-up analysis of a clinical pilot trial 2013 ·Cancer Immunology Immunotherapy ·Christoph Domschke, Yingzi Ge, (unknown), Sarah Schott, (unknown), (unknown), Mariana Bucur, (unknown), Maria Blumenstein, Joachim Rom, Joerg Heil, Christof Sohn, Andreas Schneeweiß, Philipp Beckhove, Florian Schuetz	42
6	Rapid T cell–based identification of human tumor tissue antigens by automated two-dimensional protein fractionation 2010 ·Journal of Clinical Investigation ·Philipp Beckhove, Rolf Warta, (unknown), (unknown), Frank Momburg, Martina Schnölzer, Uwe Warnken, Hubertus Schmitz‐Winnenthal, Rezvan Ahmadi, Gerhard Dyckhoff, Mariana Bucur, (unknown), Thomas Schueler, Volker Lennerz, Thomas Woelfel, Andreas Unterberg, Christel Herold‐Mende	16
7	Melanoma-Reactive T Cells in the Bone Marrow of Melanoma Patients: Association with Disease Stage and Disease Duration 2006 ·Cancer Research ·Jan Müller‐Berghaus, (unknown), Selma Ugurel, Viktor Umansky, Mariana Bucur, Volker Schirrmacher, Philipp Beckhove, Dirk Schadendorf	29
8	Tumor selective replication of Newcastle disease virus: Association with defects of tumor cells in antiviral defence 2006 ·International Journal of Cancer ·(unknown), Ben Peeters, Philippe Fournier, Annette Arnold, Mariana Bucur, Volker Schirrmacher	113
9	Specific immune recognition of pancreatic carcinoma by patient-derived CD4 and CD8 T cells and its improvement by interferon-γ 2006 ·International Journal of Oncology ·(unknown), (unknown), Philipp Beckhove, Volker Schirrmacher, Mariana Bucur, (unknown), Christine Volk, Bruno M. Schmied, (unknown), Dalibor Antolovic, Jürgen Weitz, (unknown), Kaspar Z’graggen	23
10	Heparanase Expression at the Invasion Front of Human Head and Neck Cancers and Correlation with Poor Prognosis 2005 ·Clinical Cancer Research ·Philipp Beckhove, Burkhard Helmke, (unknown), Mariana Bucur, Wolfgang Dörner, Carolin Mogler, Gerhard Dyckhoff, Christel Herold‐Mende	41
11	Enrichment of functional CD8 memory T cells specific for MUC1 in Bone Marrow of Multiple Myeloma Patients 2004 ·Cancer Cell International ·Mathias Witzens‐Harig, Carmen Choi, Mariana Bucur, Markus Feuerer, Nora Sommerfeldt, Andreas Trojan, Anthony D. Ho, Volker Schirrmacher, Hartmut Goldschmidt, Philipp Beckhove	7
12	Inhibition of Nitric-Oxide-Mediated Apoptosis in Jurkat Leukemia Cells despite Cytochrome c Release 2001 ·Experimental Cell Research ·Victor Umansky, Frank Ratter, Stefan Lampel, Mariana Bucur, Volker Schirrmacher, Alexey Ushmorov	15
13	Glutathione is a factor of resistance of Jurkat leukemia cells to nitric oxide-mediated apoptosis 2000 ·Journal of Cellular Biochemistry ·Victor Umansky, Marian Rocha, Raoul Breitkreutz, Steffen P. Hehner, Mariana Bucur, (unknown), (unknown), Alexey Ushmorov	40
14	Nitric oxide-mediated apoptosis in human breast cancer cells requires changes in mitochondrial functions and is independent of CD95 (APO-1/Fas). 2000 ·International Journal of Oncology ·Victor Umansky, Alexey Ushmorov, Frank Ratter, Katerina Chlichlia, Mariana Bucur, (unknown), (unknown)	39
15	Breaking tolerance to a tumor-associated viral superantigen as a basis for graft-versus-leukemia reactivity 2000 ·International Journal of Cancer ·Volker Schirrmacher, Susanne Sebens Müerköster, Mariana Bucur, Victor Umansky, (unknown)	10
16	Caspase Activation Is Required for Nitric Oxide–Mediated, CD95(APO-1/Fas)–Dependent and Independent Apoptosis in Human Neoplastic Lymphoid Cells 1998 ·Blood ·Katerina Chlichlia, Marcus E. Peter, Marian Rocha, Carsten Scaffidi, Mariana Bucur, Peter H. Krammer, Volker Schirrmacher, Victor Umansky	68
17	Caspase Activation Is Required for Nitric Oxide–Mediated, CD95(APO-1/Fas)–Dependent and Independent Apoptosis in Human Neoplastic Lymphoid Cells 1998 ·Blood ·Katerina Chlichlia, Marcus E. Peter, Marian Rocha, Carsten Scaffidi, Mariana Bucur, Peter H. Krammer, Volker Schirrmacher, Victor Umansky	3
18	Activated endothelial cells induce apoptosis in lymphoma cells 1997 ·International Journal of Oncology ·Victor Umansky, Mariana Bucur, Volker Schirrmacher, (unknown)	21
19	[Value of leucotrophin as an adjuvant in anti-tumor radiotherapy]. 1980 ·PubMed ·(unknown), (unknown), (unknown), Mariana Bucur, (unknown)	1
20	[Plasma cell mastitis]. 1970 ·PubMed ·Mariana Bucur, (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact